Study: Drug for weight loss lowers type 2 diabetes risk in obese patients

10/11/2013 | MedPage Today (free registration)

Overweight and obese patients who took the weight-loss drug Qsymia were 70.5% to 78.7% less likely than those in the placebo group to develop type 2 diabetes, a study found. Patients in the Qsymia arm also showed greater weight loss at 108 weeks compared with the controls, researchers wrote on the website of Diabetes Care.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL